Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors-Reference-Cited by-同舟云学术

Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors

Published:2018-03 Issue:3 Volume:14 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Azimi Alireza¹,Caramuta Stefano¹,Seashore‐Ludlow Brinton²,Boström Johan³^ORCID,Robinson Jonathan L⁴,Edfors Fredrik⁵,Tuominen Rainer¹,Kemper Kristel⁶,Krijgsman Oscar⁶^ORCID,Peeper Daniel S⁶^ORCID,Nielsen Jens⁴^ORCID,Hansson Johan¹,Egyhazi Brage Suzanne¹,Altun Mikael³^ORCID,Uhlen Mathias⁵^ORCID,Maddalo Gianluca⁵^ORCID

Affiliation:

1. Department of Oncology‐Pathology Karolinska Institutet Karolinska University Hospital Stockholm Sweden

2. Chemical Biology Consortium Sweden, Science for Life Laboratory Division of Translational Medicine and Chemical Biology Department of Medical Biochemistry and Biophysics Karolinska Institutet Stockholm Sweden

3. Science for Life Laboratory Division of Translational Medicine and Chemical Biology Department of Medical Biochemistry and Biophysics Karolinska Institutet Stockholm Sweden

4. Department of Biology and Biological Engineering Chalmers University of Technology Göteborg Sweden

5. Science for Life Laboratory School of Biotechnology KTH Royal Institute of Technology Stockholm Sweden

6. Division of Molecular Oncology & Immunology The Netherlands Cancer Institute Amsterdam The Netherlands

Funder

Radiumhemmets Forskningsfonder

O. E. och Edla Johanssons Vetenskapliga Stiftelse

Stiftelsen Lars Hiertas Minne

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.20177858

Reference58 articles.

1. Signatures of mutational processes in human cancer

2. Combinatorial drug therapy for cancer in the post-genomic era

3. Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells

4. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

5. Fifteen-year quest for microphthalmia-associated transcription factor target genes

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics analysis delineates resistance mechanisms associated with BRAF inhibition in melanoma cells;Experimental Cell Research;2024-09

2. Subcellular thermal profiling enables the deep functional exploration of the mitochondrial proteome;2024-02-29

3. Protein translation: biological processes and therapeutic strategies for human diseases;Signal Transduction and Targeted Therapy;2024-02-23

4. Spatiotemporal profiling defines persistence and resistance dynamics during targeted treatment of melanoma;2024-02-05

5. P129, a pyrazole ring-containing isolongifolanone-derivate: synthesis and investigation of anti-glioma action mechanism;Discover Oncology;2024-01-06